Perioperative management of the left ventricular assist device recipient

Progress in Cardiovascular Diseases

Volumn 43, Issue 1, 2000, Pages 47-54

  Heath, Mark J S ^a   Dickstein, Marc L ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHESIA INDUCTION; ASSISTED CIRCULATION; DEVICE; HEART ARRHYTHMIA; HEART FAILURE; HEART RIGHT VENTRICLE FAILURE; HUMAN; PATHOPHYSIOLOGY; PERIOPERATIVE PERIOD; PREOPERATIVE EVALUATION; REVIEW; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT INDICATION;

EID: 0033915031     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1053/pcad.2000.7197     Document Type: Article

References (27)

1. Braunwald E. Pathophysiology of heart failure. Braunwald E. Heart Disease: A Textbook of Cardiovascular Medicine. 1992;393-418 Saunders, Philadelphia, PA
2. Kapoor AS, Laks H, Schroeder JS, et al. Cardiomyophayies and Heart-Lung Transplantation. ed 1 :1991;McGraw-Hill, New York, NY
3. Francis GS, Goldsmith SR, Levine TB, et al. The neurohumoral axis in congestive heart failure. Ann Intern Med. 101:1984;370-377
4. Levine TB, Francis GS, Goldsmith SR, et al. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol. 49:1982;1659-1666
5. Stevenson LW, Tillish JH. Maintenance of cardiac output with normal filling pressure in patients with dilated heart failure. Circulation. 74:1986;1303-1308
6. Levine TB. Role of vasodilators in the treatment of congestive heart failure. Am J Cardiol. 55:1985;32A-35A
7. Kono T, Sabbah HN, Stein PD, et al. Left ventricular shape as a determinant of functional mitral regurgitation in patients with severe heart failure secondary to either coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol. 68:1991;355-359
8. Packer M. Role of the sympathetic nervous system in chronic heart failure: A historical and philosophical perspective. Circulation. 82:1990;11-16
9. Spinale FG, Tempel GE, Mukherjee R, et al. Cellular and molecular alterations in beta-adrenergic system with cardiomyopathy induced by tachycardia. Cardiovasc Res. 28:1994;1243-1250
10. Bristow M, Hershberger R, Port J, et al. Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium. Mol Pharmacol. 35:1989;295-303
11. Kawaguchi A, Gandjbakhch I, Pavie A, et al. Cardiac transplant recipients with preoperative pulmonary hypertension: Evolution of pulmonary hemodynamics and surgical options. Circulation. 80:1989;III90-III96
12. Campione KM. Heart to head circulation time. Illinois Medical J. 141:1972;75-77
13. Waterman PM. Rapid sequence induction technique in patients with severe ventricular dysfunction. J Cardiothorac Vasc Anesth. 2:1988;602-606
14. Starling RC, Binkley PF, Haas GJ, et al. Thermodilution measures of right ventricular ejection fraction and volumes in heart transplant recipients: A comparison with radionuclide angiography. J Heart Lung Transplant. 11:1992;1140-1146
15. Chen EP, Bittner HB, Davis RDJ, et al. Milrinone improves pulmonary hemodynamics and right ventricular function in chronic pulmonary hypertension. Ann Thorac Surg. 63:1997;814-821
16. Frostell C, Fratacci M, Wain JC, et al. Inhaled nitric oxide: A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation. 83:1991;2038-2047
17. Argenziano M, Choudhri AF, Moazami N, et al. Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Ann Thorac Surg. 65:1998;340-345
18. Putensen C, Rasanen J, Lopez FA. Improvement in VA/Q distributions during inhalation of nitric oxide in pigs with methacholine-induced bronchoconstriction. Am J Respir Crit Care Med. 151:1995;116-122
19. Semigran MJ, Cockrill BA, Kacmarek R, et al. Hemodynamic effects of inhaled nitric oxide in heart failure. J Am Coll Cardiol. 24:1994;982-988
20. Shipley JB, Tolman D, Hastillo A, et al. Milrinone: Basic and clinical pharmacology and acute and chronic management. J Med Sci. 311:1996;286-291
21. Frazier OH, Rose EA, Macmanus Q. Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. Ann Thoracic Surg. 53:1992;1080-1090
22. Dickstein ML, Todaka K, Burkhoff D. Left-to-right systolic and diastolic ventricular interactions are dependent on right ventricular volume. Am J Physiol. 272:1997;H2869-H2874
23. Chow E, Farrar DJ. Right heart function during prosthetic left ventricular assistance in a porcine model of congestive heart failure. J Thorac Cardiovasc Surg. 104:1992;569-578
24. Moroney DA, Swartz MT, Reedy JE, et al. Importance of ventricular arrhythmias in recovery patients with ventricular assist devices. ASAIO Trans. 37:1991;M516-M517
25. Goldstein DJ, Seldomridge JA, Chen JM, et al. Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality. Ann Thorac Surg. 59:1995;1063-1067
26. Thiele RI, Jakob H, Hund E, et al. Critical illness polyneuropathy: A new iatrogenically induced syndrome after cardiac surgery? Eur J Cardiothorac Surg. 12:1997;826-835
27. Nauwynck M, Huyghens L. Neurological complications in critically ill patients; Septic encephalopathy, critical illness polyneuropathy. Acta Clin Belg. 53:1998;92-97